Details
Stereochemistry | ACHIRAL |
Molecular Formula | C26H36N2O5 |
Molecular Weight | 456.5744 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(CC(=O)N(CCCN(C)CCC3=CC(OC)=C(OC)C=C3)CC2)C=C1OC
InChI
InChIKey=KEDQCFRVSHYKLR-UHFFFAOYSA-N
InChI=1S/C26H36N2O5/c1-27(13-9-19-7-8-22(30-2)23(15-19)31-3)11-6-12-28-14-10-20-16-24(32-4)25(33-5)17-21(20)18-26(28)29/h7-8,15-17H,6,9-14,18H2,1-5H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/20795648Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/15648302 | https://www.ncbi.nlm.nih.gov/pubmed/14561092 |
https://www.ncbi.nlm.nih.gov/pubmed/19093365
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20795648
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/15648302 | https://www.ncbi.nlm.nih.gov/pubmed/14561092 |
https://www.ncbi.nlm.nih.gov/pubmed/19093365
Zatebradine is a bradycardic compound that blocks hyperpolarization-activated inward current (If) through cyclic nucleotide-gated cation (HCN) channels in sinoatrial node cells. Additionally, it can block voltage-gated outward K+ (IK) currents and related neuronal hyperpolarization-activated inward current (Ih) channels but exhibits little or no activity for L-type Ca2+ (ICa) currents. When assessed through telemetric ECG recording in mice, zatebradine reduced heart rate from 600 to 200 beats per minute with an ED50 value of 1.8 mg/kg and induced increasing arrhythmia at concentrations >10 mg/kg.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1250417 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20795648 |
8.57 µM [EC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Specific bradycardic agents, a new therapeutic modality for anesthesiology: hemodynamic effects of UL-FS 49 and propranolol in conscious and isoflurane-anesthetized dogs. | 1987 Nov |
|
Zatebradine attenuates cyclic AMP-related positive chronotropic but not inotropic responses in isolated, perfused right atria of the dog. | 1995 Jan |
|
Bradycardic and proarrhythmic properties of sinus node inhibitors. | 2006 Apr |
|
The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity. | 2013 Mar |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19093365
Rats were treated with Zatebradine at dose 3 mg/kg i.v
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22107837
Sinoatrial node pacemaker cells were isolated enzymatically from rabbit hearts. The inward currents, elicited by hyperpolarizing pulses of 2000 ms from a holding potential of −40 mV to −140 mV in 10 mV increments and then clamp back to 0 mV for 1000 ms, were recorded first in the absence and then in the presence of zatebradine or CsCl. The established If blockers zatebradine (1 mkM) and CsCl (2 mM) inhibited If by 63.7 ± 8.4% and 91.8 ± 5.6%, respectively
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47793
Created by
admin on Fri Dec 15 15:42:59 GMT 2023 , Edited by admin on Fri Dec 15 15:42:59 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C66687
Created by
admin on Fri Dec 15 15:42:59 GMT 2023 , Edited by admin on Fri Dec 15 15:42:59 GMT 2023
|
PRIMARY | |||
|
C043636
Created by
admin on Fri Dec 15 15:42:59 GMT 2023 , Edited by admin on Fri Dec 15 15:42:59 GMT 2023
|
PRIMARY | |||
|
m11583
Created by
admin on Fri Dec 15 15:42:59 GMT 2023 , Edited by admin on Fri Dec 15 15:42:59 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID1048413
Created by
admin on Fri Dec 15 15:42:59 GMT 2023 , Edited by admin on Fri Dec 15 15:42:59 GMT 2023
|
PRIMARY | |||
|
65637
Created by
admin on Fri Dec 15 15:42:59 GMT 2023 , Edited by admin on Fri Dec 15 15:42:59 GMT 2023
|
PRIMARY | |||
|
TV27RY5876
Created by
admin on Fri Dec 15 15:42:59 GMT 2023 , Edited by admin on Fri Dec 15 15:42:59 GMT 2023
|
PRIMARY | |||
|
CHEMBL69679
Created by
admin on Fri Dec 15 15:42:59 GMT 2023 , Edited by admin on Fri Dec 15 15:42:59 GMT 2023
|
PRIMARY | |||
|
100000079372
Created by
admin on Fri Dec 15 15:42:59 GMT 2023 , Edited by admin on Fri Dec 15 15:42:59 GMT 2023
|
PRIMARY | |||
|
SUB00143MIG
Created by
admin on Fri Dec 15 15:42:59 GMT 2023 , Edited by admin on Fri Dec 15 15:42:59 GMT 2023
|
PRIMARY | |||
|
85175-67-3
Created by
admin on Fri Dec 15 15:42:59 GMT 2023 , Edited by admin on Fri Dec 15 15:42:59 GMT 2023
|
PRIMARY | |||
|
6240
Created by
admin on Fri Dec 15 15:42:59 GMT 2023 , Edited by admin on Fri Dec 15 15:42:59 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)